BioSpace News Archive

Rev. Fr. Emmanuel Lemelson, the Chief Investment Officer of Lemelson Capital Management, today responded to a civil complaint filed by the United States Securities and Exchange Commission in the United States District Court of Massachusetts, Boston Divisio

The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a quarterly dividend of forty cents ($0.40) per share on the $.10 par value Common Stock of the corporation.

The Biotechnology Innovation Organization (BIO) today applauded the introduction of the American Innovation Act of 2018 (H.R. 6756), which includes a provision that would protect investments in start-ups from inadvertently triggering the net operating loss (NOL) limitations under Section 382 of the tax code

The House of Representatives passed the Local Coverage Determination Clarification Act, which aims to improve accountability and transparency in the process Medicare contractors use to make local coverage decisions. The legislation passed the House by a voice vote on September 12.

Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the consolidation of its licensing position and reestablishment of control of its intellectual property in the in vitro diagnostics (IVD) field.

Pomerantz LLP is investigating claims on behalf of investors of Alnylam Pharmaceuticals, Inc.

Vanda Pharmaceuticals Inc. today announced the results of a HETLIOZ® (tasimelteon) driving study to measure next day performance.

Asymchem today announced that its Tianjin 2 site, a multi-purpose development and commercial API manufacturing facility, successfully passed the U.S. Food and Drug Administration (USFDA) general GMP reinspection conducted between July 23-26, 2018 with no Form 483 issued.

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alnylam Pharmaceuticals, Inc.

The National Safety Council and the National Institute for Occupational Safety and Health (NIOSH) are renewing their partnership and agreeing to leverage their organizations’ expertise, best practices, resources and strategies in order to engage employers in the quest to eliminate preventable workplace deaths